The aim of the current study was to utilize the amplitude of the mismatch negativity (MMN) component to assess auditory sensory memory for duration in individuals with CLN3 disease, on the premise that this easy-to-test neurophysiological marker might be sensitive to subtle changes in auditory cortical processing in this progressive neurodevelopmental disorder. This evidence concerns the gene CLN3 and neurodevelopmental disorder.